The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?

[1]  P. Kantoff,et al.  Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. , 2020, European urology.

[2]  K. Kuroiwa,et al.  Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study , 2019, Cancer Chemotherapy and Pharmacology.

[3]  M. Parmar,et al.  Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis , 2019, European urology.

[4]  Ronald C. Chen,et al.  A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer. , 2019, European urology oncology.

[5]  A. Amini,et al.  Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging? , 2019, European urology.

[6]  A. Zwinderman,et al.  Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. , 2019, European urology.

[7]  K. Kuroiwa,et al.  Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study , 2019, Medical Oncology.

[8]  A. Partin,et al.  Adjuvant radiation with androgen‐deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit , 2019, BJU international.

[9]  E. Crawford,et al.  A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III) , 2019, The Journal of urology.

[10]  D. Elashoff,et al.  Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT] , 2019, BMC Cancer.

[11]  M. Parmar,et al.  Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial , 2018, The Lancet.

[12]  M. Menon,et al.  Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection. , 2018, European urology.

[13]  Thomas Wiegel,et al.  Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. , 2018, European urology.

[14]  M. Carducci,et al.  Impact of ethnicity on the outcome of men with metastatic, hormone‐sensitive prostate cancer , 2017, Cancer.

[15]  M. Parmar,et al.  Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial. , 2016, JAMA oncology.

[16]  A. Jemal,et al.  Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer. , 2015, Journal of the National Cancer Institute.

[17]  Cesare Cozzarini,et al.  Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Crawford,et al.  The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. , 2014, International journal of radiation oncology, biology, physics.

[19]  J. Tward,et al.  Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival. , 2013, Practical radiation oncology.

[20]  Susan Halabi,et al.  Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Malone,et al.  Prostate , 1995 .

[22]  H. Sakuma,et al.  Multimodality Treatment for Patients with Node-Positive Prostate Cancer: the Role of Radiation Therapy. , 2016, Asian Pacific journal of cancer prevention : APJCP.